Bayer shares: Analysts maintain price target at 23 euros despite strong Q1 figures!

Bayer shares: Analysts maintain price target at 23 euros despite strong Q1 figures!

On May 13, 2025, Bayer shares rose by 7.9 percent to 25.97 euros after analyst Falko Friedrichs from Deutsche Bank AG published a new valuation. In the investigation, the rating for the Bayer shares is left at “Hold”, with a price target of 23 euros. XETRA volume reached 6,886,363 Bayer shares traded on the day, reflecting current investor interest.

Deutsche Bank Research reports that Bayer significantly exceeded expectations in the first quarter of 2025. The outlook for the company was confirmed without any currency impact and shows that the company remains on track. Still, Bayer's performance remains weak on an adjusted basis, raising concerns.

Legal risks and uncertainties

The analysts point to existing legal risks that could continue to pose a challenge in the future. There is also uncertainty about Bayer's future performance in a volatile economic environment, which is crucial for investor sentiment. The possibility of a price decrease of 11.42 percent relative to the price target is also discussed.

The first quarter financial results are scheduled for May 13, 2025. Deutsche Bank's release of the original study is also scheduled for the same day, which could influence today's market.

Overall, there is a mixed picture for Bayer shares, which are not without risks despite a positive quarterly report. The legal challenges and the uncertainties of the global markets could be decisive for the future development of the stock.

For more information on this analysis, see reports from finance.net and boerse.de.